[Some immunological findings in malignant melanoma (author's transl)]. 1980

J Richter, and V Král, and H Duchková, and M Kubíková

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009961 Orosomucoid Acid Seromucoid,Seromucoid,Serum Sialomucin,alpha 1-Acid Glycoprotein,alpha 1-Acid Seromucoid,A(1)-Acid Seromucoid,Acid alpha 1-Glycoprotein,Alpha(1)-Acid Glycoprotein,alpha 1-Acid Glycoprotein (Acute Phase),alpha 1-Glycoprotein Acid,Acid alpha 1 Glycoprotein,Glycoprotein, alpha 1-Acid,Seromucoid, Acid,Seromucoid, alpha 1-Acid,Sialomucin, Serum,alpha 1 Acid Glycoprotein,alpha 1 Acid Seromucoid,alpha 1 Glycoprotein Acid
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D005260 Female Females
D006466 Hemopexin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Richter, and V Král, and H Duchková, and M Kubíková
January 1981, No shinkei geka. Neurological surgery,
J Richter, and V Král, and H Duchková, and M Kubíková
January 1980, Ceskoslovenska dermatologie,
J Richter, and V Král, and H Duchková, and M Kubíková
February 1981, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
J Richter, and V Král, and H Duchková, and M Kubíková
January 1982, Dermatologische Monatschrift,
J Richter, and V Král, and H Duchková, and M Kubíková
November 1981, Klinische Monatsblatter fur Augenheilkunde,
J Richter, and V Král, and H Duchková, and M Kubíková
October 1978, Dermatologische Monatschrift,
J Richter, and V Král, and H Duchková, and M Kubíková
January 1974, Radiobiologia, radiotherapia,
J Richter, and V Král, and H Duchková, and M Kubíková
June 1981, La Nouvelle presse medicale,
J Richter, and V Král, and H Duchková, and M Kubíková
November 1976, Langenbecks Archiv fur Chirurgie,
J Richter, and V Král, and H Duchková, and M Kubíková
March 1979, Medizinische Klinik,
Copied contents to your clipboard!